Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol for Methamphetamine Relapse Prevention
NCT00442923Phase 2Withdrawn
- Start
- Jul 2007
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carvedilol in methamphetamine use disorder (MUD). Planned start Jul 2007; status: withdrawn.
02
Drugs
carvedilol
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT00442923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442923.